Vakharia insights from the ARCHER trial on geographic atrophy treatment for dry AMD, highlighting promising results and ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Dr Michael Ekuoba Gyasi, Executive Director of St. Thomas Eye Hospital, was honored as CEO of the Year in Health Care – Eye ...

Roshni Bhat, BS, presented the study on behalf of the Harvard Ophthalmology Metabolomics in Retina (HOMeR) program, which focuses on understanding the mechanisms of AMD progression. The team conducted ...

In a moment that drew applause and admiration from Ghana’s top business and political leaders, Dr. Michael Ekuoba Gyasi, Executive Director of St. Thomas ...

Any thoughts on milk thistle supplements in fatty liver disease that was diagnosed by an ultrasound due to elevated AST and ...

In this video, Jay Chhablani, MD, discusses findings from the LIGHTSITE 3B study presented at the ARVO meeting on the long-term use of photobiomodulation in dry age-related macular degeneration.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

What is the difference between prediabetes and diabetes, and which do I have? I am male, 85 years old, 170 pounds, and 6 feet ...

discusses findings from the LIGHTSITE 3B study presented at the ARVO meeting on the long-term use of photobiomodulation in dry age-related macular degeneration. The FDA granted rare pediatric ...

Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...